Age and Multimorbidity Predict Death Among COVID-19 Patients

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics

(2020) David Gurwitz   DRUG DEVELOPMENT RESEARCH

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

COVID-19 and the cardiovascular system

(2020) Ying-Ying Zheng et al.   Nature Reviews Cardiology

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

(2020) Peng Zhang et al.   CIRCULATION RESEARCH

Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations

(2020) Thomas C Hanff et al.   CLINICAL INFECTIOUS DISEASES

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

(2020) Wei-jie Guan et al.   EUROPEAN RESPIRATORY JOURNAL

Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?

(2020) Murray Esler et al.   JOURNAL OF HYPERTENSION

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

(2020) James H Diaz   JOURNAL OF TRAVEL MEDICINE

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

(2020) Giuseppe Mancia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

(2020) Muthiah Vaduganathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers

(2020) Riccardo Sarzani et al.   European Journal of Preventive Cardiology

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients

(2020) Gian Paolo Rossi et al.   eLife

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?

(2020) Allegra Battistoni et al.   European Heart Journal-Cardiovascular Pharmacotherapy

COVID-19, SARS and MERS: are they closely related?

(2020) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Renin-Angiotensin System Blockers and the COVID-19 Pandemic

(2020) A.H. Jan Danser et al.   HYPERTENSION

Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands

(2019) Isadora Prado Cano et al.   PLoS One

We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome

(2019) Gaetano Santulli et al.   Journal of Clinical Medicine

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   JOURNAL OF HYPERTENSION

Therapeutic time window for angiotensin-(1-7) in acute lung injury

(2016) Stefanie Supé et al.   BRITISH JOURNAL OF PHARMACOLOGY

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

(2015) Vineet D Menachery et al.   NATURE MEDICINE

Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors

(2014) Raphael N. Vuille-dit-Bille et al.   AMINO ACIDS